A randomized, double-blind, active placebo-controlled study of efficacy, safety, and durability of repeated vs single subanesthetic ketamine for treatment-resistant depression Read More > June 26, 2020
Integrating psychotherapy and psychopharmacology: psychedelic-assisted psychotherapy and other combined treatments Read More > June 12, 2020
Esketamine Nasal Spray for Rapid Reduction of Major Depressive Disorder Symptoms in Patients Who Have Active Suicidal Ideation With Intent: Double-Blind, Randomized Study (ASPIRE I) Read More > May 12, 2020
Can Psychedelics Alleviate Symptoms of Cluster Headache and Accompanying Mental Health Problems? A Case Report Involving Hawaiian Baby Woodrose Read More > May 7, 2020
The Viability of Microdosing Psychedelics as a Strategy to Enhance Cognition and Well-being – An Early Review Read More > May 2, 2020
A Single Administration of the Atypical Psychedelic Ibogaine or Its Metabolite Noribogaine Induces an Antidepressant-Like Effect in Rats Read More > April 24, 2020
Registered Clinical Trials Investigating Ketamine for Psychiatric Disorders Read More > April 9, 2020
